NASDAQ:MORF

Morphic News Headlines

$59.35
-1.78 (-2.91 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$57.56
Now: $59.35
$62.06
50-Day Range
$32.85
MA: $58.78
$84.85
52-Week Range
$12.09
Now: $59.35
$93.00
Volume126,609 shs
Average Volume418,360 shs
Market Capitalization$1.93 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.01

Headlines

Morphic (NASDAQ MORF) News Headlines Today

SourceHeadline
Morphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 11,449 SharesMorphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 11,449 Shares
americanbankingnews.com - April 9 at 1:34 PM
Morphic Holding, Inc. (NASDAQ:MORF) Director Sells $592,715.73 in StockMorphic Holding, Inc. (NASDAQ:MORF) Director Sells $592,715.73 in Stock
americanbankingnews.com - April 7 at 4:30 PM
Fund V. L.P. Omega Sells 16,784 Shares of Morphic Holding, Inc. (NASDAQ:MORF) StockFund V. L.P. Omega Sells 16,784 Shares of Morphic Holding, Inc. (NASDAQ:MORF) Stock
americanbankingnews.com - April 2 at 1:36 PM
Insider Selling: Morphic Holding, Inc. (NASDAQ:MORF) Director Sells 16,168 Shares of StockInsider Selling: Morphic Holding, Inc. (NASDAQ:MORF) Director Sells 16,168 Shares of Stock
americanbankingnews.com - March 31 at 7:48 PM
Morphic Holding, Inc. (NASDAQ:MORF) Director Fund V. Gp L.P. Omega Sells 47,937 SharesMorphic Holding, Inc. (NASDAQ:MORF) Director Fund V. Gp L.P. Omega Sells 47,937 Shares
americanbankingnews.com - March 29 at 1:28 PM
Morphic Holding, Inc. (NASDAQ:MORF) Short Interest Down 44.5% in MarchMorphic Holding, Inc. (NASDAQ:MORF) Short Interest Down 44.5% in March
americanbankingnews.com - March 29 at 9:44 AM
Morphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 32,971 SharesMorphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 32,971 Shares
americanbankingnews.com - March 25 at 1:30 PM
Morphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 16,629 SharesMorphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 16,629 Shares
americanbankingnews.com - March 23 at 5:24 PM
Morphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 9,153 SharesMorphic Holding, Inc. (NASDAQ:MORF) Director Fund V. L.P. Omega Sells 9,153 Shares
americanbankingnews.com - March 23 at 4:50 PM
Morphic Holding, Inc. (NASDAQ:MORF) Director Sells $1,052,315.44 in StockMorphic Holding, Inc. (NASDAQ:MORF) Director Sells $1,052,315.44 in Stock
americanbankingnews.com - March 19 at 1:47 PM
William Devaul Sells 14,027 Shares of Morphic Holding, Inc. (NASDAQ:MORF) StockWilliam Devaul Sells 14,027 Shares of Morphic Holding, Inc. (NASDAQ:MORF) Stock
americanbankingnews.com - March 17 at 7:40 PM
Insider Selling: Morphic Holding, Inc. (NASDAQ:MORF) Insider Sells 8,509 Shares of StockInsider Selling: Morphic Holding, Inc. (NASDAQ:MORF) Insider Sells 8,509 Shares of Stock
americanbankingnews.com - March 17 at 7:40 PM
Fund V. L.P. Omega Sells 36,532 Shares of Morphic Holding, Inc. (NASDAQ:MORF) StockFund V. L.P. Omega Sells 36,532 Shares of Morphic Holding, Inc. (NASDAQ:MORF) Stock
americanbankingnews.com - March 17 at 10:43 AM
Morphic Holding Inc (MORF) CFO and COO Marc Schegerin Bought $190,500 of SharesMorphic Holding Inc (MORF) CFO and COO Marc Schegerin Bought $190,500 of Shares
finance.yahoo.com - March 11 at 7:43 AM
Independent Director Vikas Goyal Just Bought A Handful Of Shares In Morphic Holding, Inc. (NASDAQ:MORF)Independent Director Vikas Goyal Just Bought A Handful Of Shares In Morphic Holding, Inc. (NASDAQ:MORF)
nasdaq.com - March 9 at 1:25 PM
Morphic price target raised at Wells Fargo on positive data in inflammatory bowel diseaseMorphic price target raised at Wells Fargo on positive data in inflammatory bowel disease
seekingalpha.com - March 3 at 1:22 PM
Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public OfferingMorphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
finance.yahoo.com - March 3 at 12:38 AM
Why Morphic Holding Stock Is Falling TodayWhy Morphic Holding Stock Is Falling Today
finance.yahoo.com - March 2 at 2:34 PM
Best Stocks To Buy Now? 4 Health Care Stocks To WatchBest Stocks To Buy Now? 4 Health Care Stocks To Watch
marketwatch.com - March 2 at 9:34 AM
FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INOs REVEAL 1 Meets GoalsFDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO's REVEAL 1 Meets Goals
nasdaq.com - March 2 at 4:33 AM
Why Morphic, Athenex, Lixte Biotech Are Moving TodayWhy Morphic, Athenex, Lixte Biotech Are Moving Today
msn.com - March 1 at 5:24 PM
Why Morphic Holding Stock Is Skyrocketing TodayWhy Morphic Holding Stock Is Skyrocketing Today
finance.yahoo.com - March 1 at 5:24 PM
Morphic Therapeutic Announces Proposed Public OfferingMorphic Therapeutic Announces Proposed Public Offering
finance.yahoo.com - March 1 at 5:24 PM
Morphic Holding, Inc. (MORF) Reports Q4 Loss, Misses Revenue EstimatesMorphic Holding, Inc. (MORF) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 1 at 12:24 PM
Morphic Holding Inc to Host Earnings CallMorphic Holding Inc to Host Earnings Call
finance.yahoo.com - March 1 at 7:23 AM
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2020Morphic Announces Corporate Highlights and Financial Results for the Full Year 2020
finance.yahoo.com - March 1 at 7:23 AM
Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057
finance.yahoo.com - March 1 at 7:23 AM
Morphic Therapeutic to Host Analyst and Investor Call on March 1, 2021Morphic Therapeutic to Host Analyst and Investor Call on March 1, 2021
finance.yahoo.com - February 22 at 3:35 PM
Will Morphic Holding, Inc. (MORF) Report Negative Q4 Earnings? What You Should KnowWill Morphic Holding, Inc. (MORF) Report Negative Q4 Earnings? What You Should Know
nasdaq.com - February 19 at 10:32 AM
Morphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care ConferenceMorphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care Conference
finance.yahoo.com - February 16 at 8:00 PM
Is Morphic Holdings (NASDAQ:MORF) Share Price Gain Of 101% Well Earned?Is Morphic Holding's (NASDAQ:MORF) Share Price Gain Of 101% Well Earned?
finance.yahoo.com - February 9 at 2:16 PM
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin ProgramMorphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
finance.yahoo.com - January 5 at 12:19 PM
Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare ConferenceMorphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 30 at 12:48 PM
Morphic Holdings (MORF) Shares March Higher, Can It Continue?Morphic Holding's (MORF) Shares March Higher, Can It Continue?
finance.yahoo.com - December 15 at 10:12 AM
Is MORF A Good Stock To Buy Now?Is MORF A Good Stock To Buy Now?
finance.yahoo.com - December 9 at 6:17 PM
Morphic Therapeutic Announces Appointment of Dr. Martin W. Edwards as Member of its Board of DirectorsMorphic Therapeutic Announces Appointment of Dr. Martin W. Edwards as Member of its Board of Directors
finance.yahoo.com - December 4 at 6:15 PM
News for Morphic Holding Inc Registered ShsNews for Morphic Holding Inc Registered Shs
markets.businessinsider.com - November 30 at 6:02 PM
Results: Morphic Holding, Inc. Confounded Analyst Expectations With A Surprise ProfitResults: Morphic Holding, Inc. Confounded Analyst Expectations With A Surprise Profit
finance.yahoo.com - November 11 at 8:27 AM
Morphic EPS beats by $0.71, beats on revenueMorphic EPS beats by $0.71, beats on revenue
seekingalpha.com - November 9 at 8:43 AM
Morphic Announces Corporate Highlights and Third Quarter 2020 Financial ResultsMorphic Announces Corporate Highlights and Third Quarter 2020 Financial Results
finance.yahoo.com - November 9 at 8:43 AM
We Think Morphic Holding (NASDAQ:MORF) Can Easily Afford To Drive Business GrowthWe Think Morphic Holding (NASDAQ:MORF) Can Easily Afford To Drive Business Growth
finance.yahoo.com - November 5 at 1:06 PM
Morphic Announces Presentation of New Data Supporting Development of MORF-057 at UEG Week Virtual 2020Morphic Announces Presentation of New Data Supporting Development of MORF-057 at UEG Week Virtual 2020
markets.businessinsider.com - October 12 at 9:20 AM
Morphic Holding, Inc. (31Y.F)Morphic Holding, Inc. (31Y.F)
in.finance.yahoo.com - October 11 at 6:18 PM
Morphic Therapeutic Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of MORF-057Morphic Therapeutic Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of MORF-057
finance.yahoo.com - September 23 at 9:15 AM
AbbVie opts in to develop fibrotic disease candidates with MorphicAbbVie opts in to develop fibrotic disease candidates with Morphic
seekingalpha.com - August 25 at 8:42 AM
Morphic Announces that AbbVie Exercises License Option to αvB6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic DiseasesMorphic Announces that AbbVie Exercises License Option to αvB6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases
marketwatch.com - August 25 at 8:42 AM
Morphic Announces that AbbVie Exercises License Option to αvβ6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic DiseasesMorphic Announces that AbbVie Exercises License Option to αvβ6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases
finance.yahoo.com - August 25 at 8:42 AM
Morphic Holding, Inc. (MORF) Reports Q2 Loss, Tops Revenue EstimatesMorphic Holding, Inc. (MORF) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 10 at 12:23 PM
Morphic EPS beats by $0.04, beats on revenueMorphic EPS beats by $0.04, beats on revenue
seekingalpha.com - August 10 at 7:19 AM
Morphic Announces Corporate Highlights and Second Quarter 2020 Financial ResultsMorphic Announces Corporate Highlights and Second Quarter 2020 Financial Results
finance.yahoo.com - August 10 at 7:19 AM
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.